Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors-Reference-Cited by-同舟云学术

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

Published:2003-09-18 Issue:4 Volume:64 Page:994-1005
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Ohta Hideo,Sato Koichi,Murata Naoya,Damirin Alatangaole,Malchinkhuu Enkhzol,Kon Junko,Kimura Takao,Tobo Masayuki,Yamazaki Yuji,Watanabe Tomoko,Yagi Mikio,Sato Motoko,Suzuki Rika,Murooka Hideko,Sakai Teruyuki,Nishitoba Tsuyoshi,Im Dong-Soon,Nochi Hiromi,Tamoto Koichi,Tomura Hideaki,Okajima Fumikazu

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid

2. Recombinant Human G Protein-Coupled Lysophosphatidic Acid Receptors Mediate Intracellular Calcium Mobilization

3. Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid

4. Lysophosphatidic Acid Receptors

5. Role of Tyrosine Kinase Activity of Epidermal Growth Factor Receptor in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Pathway

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models;Brain, Behavior, and Immunity;2024-10

2. Lysophospholipase D activity on oral mucosa cells in whole mixed human saliva involves in production of bioactive lysophosphatidic acid from lysophosphatidylcholine;Prostaglandins & Other Lipid Mediators;2024-10

3. LPA₃: Pharmacodynamic differences between lysophosphatidic acid and oleoyl-methoxy glycerophosphothionate. Biased agonism, two sites;2024-09-03

4. LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10;Acta Pharmacologica Sinica;2024-08-26

5. Lysophospholipid receptors in neurodegeneration and neuroprotection;Exploration of Neuroprotective Therapy;2024-08-22